News on Medial

Related News

Healthfab raises $1 Mn in pre-Series A round

EntrackrEntrackr · 4m ago
Healthfab raises $1 Mn in pre-Series A round
Medial

Healthfab, a reusable period panty brand, has raised $1 million in its pre-Series A funding round led by Mistry Ventures along with participation from BeyondSeed, Thrive Ventures, and distinguished investors such as Anupam Mittal, Aman Gupta, Vineeta Singh, and Peyush Bansal. Prior to this, the company had raised $336K in a seed round from BeyondSeed back in 2022. The proceeds will be utilized to expand its presence in metro and Tier 2 cities as well as invest in R&D, Healthfab said in a press release. Co-founded in 2019 by Kiriti Acharjee, Sourav Chakrabarty, and Satyajit Chakraborty, Healthfab aims to transform menstrual hygiene with convenient, comfortable, and eco-friendly solutions. The company weeds out the challenges faced by women in their families. The startup’s innovative GoPadFree Period Panty is a reusable, leak-proof solution that offers comfort, unrestricted movement, and eliminates plastic waste. It is designed for confidence and ease. According to market research, India’s feminine hygiene industry is projected to reach $2 billion by 2030 with a growing CAGR of 14.8% (2025-2030). Healthfab claims that it has become the first reusable period panty brand in India to receive BIS certification and patent protection for its innovative technology. It also states to have acquired more than 3 lakh customers along with an annual growth rate of 2.5-3x in revenue. It competes with other players in this space such as Thinx and Knix.

Biomanufacturing startup Loopworm raises $3.25 Mn in pre-Series A round

EntrackrEntrackr · 16d ago
Biomanufacturing startup Loopworm raises $3.25 Mn in pre-Series A round
Medial

Biomanufacturing startup Loopworm raises $3.25 Mn in pre-Series A round Co-founded in 2019 by Ankit Alok Bagaria and Abhi Gawri, Loopworm is a biomanufacturing startup focused on sustainable protein production using farmed insects. Loopworm, a biomanufacturing company developing insect-derived proteins, has raised $3.25 million in a pre-Series A funding round. The round was co-led by WaterBridge Ventures, an existing investor, and ENRISSION INDIA CAPITAL, a Japanese venture capital firm. The Bengaluru-based company had previously raised $3.4 million in a seed funding round led by Omnivore and others. The proceeds will be allocated towards commercializing its recombinant protein production platform, targeting diagnostics, animal vaccines, and other applications with lower regulatory barriers, Loopworm said in a press release. Loopworm focuses on sustainable protein production using farmed insects. The company has commercialized insect-derived proteins and fats for aquaculture and pet nutrition and is now developing a novel reactor-free recombinant protein production platform using silkworms. Loopworm says it has developed a new approach to producing recombinant proteins—typically created by inserting genes into host organisms like yeast or bacteria to produce proteins of medical or industrial value. Its proprietary process bypasses this entirely by using silkworms as living factories to produce complex proteins, enabling faster, more cost-effective, and sustainable production. The company currently operates a state-of-the-art, 6,000-tonne-per-year insect processing facility in Bengaluru. It exports protein and oil from silkworms and other farmed insects to Europe, South America, and ASEAN countries for use in the aquaculture and pet food industries.

Download the medial app to read full posts, comements and news.